NCT01798277 (VeTAMed) is a Phase 3 clinical trial of Catheter Ablation in Ventricular Tachycardia, sponsored by Newmarket Electrophysiology Research Group Inc.

Who is sponsoring NCT01798277?

NCT01798277 is sponsored by Newmarket Electrophysiology Research Group Inc.

What drugs are being tested in NCT01798277?

Interventions in NCT01798277: Catheter Ablation, Medical therapy (sotalol or amiodarone).

What condition does NCT01798277 study?

NCT01798277 studies Ventricular Tachycardia, Coronary Artery Disease.

Is NCT01798277 still recruiting?

NCT01798277 is currently withdrawn. Last updated 26 January 2015.

Last reviewed 2015-01-26 · How we verify

NCT01798277: VeTAMed

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ablation Versus Medical Therapy in Patients With Coronary Artery Disease and Sustained Ventricular Tachycardia Randomized Trial (VeTAMed)

Withdrawn Phase 3 Last updated 26 January 2015

What this trial tests

Phase 3 trial testing Catheter Ablation in Ventricular Tachycardia. Withdrawn.

Timeline

1 April 2013

Primary endpoint
1 June 2015

1 December 2015

Quick facts

Lead sponsor	Newmarket Electrophysiology Research Group Inc
Phase	Phase 3
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Start date	1 April 2013
Primary completion	1 June 2015
Estimated completion	1 December 2015

Drugs / interventions tested

Catheter Ablation
Medical therapy (sotalol or amiodarone) — full drug profile →

Conditions studied

Ventricular Tachycardia — all drugs for Ventricular Tachycardia →
Coronary Artery Disease — all drugs for Coronary Artery Disease →

Sponsor

Newmarket Electrophysiology Research Group Inc

Who can join

Adults 18 to 85, any sex, with Ventricular Tachycardia or Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Recurrence of Ventricular Tachycardia
Time frame: 1 year
Number of any appropriate ATPs/shocks and/or presentations of sustained (\>30sec) VT on Holter or ECG recording at 3, 6, 9 and 12 months after intervention

Sponsor's own description

This study aims to compare antiarrhythmic drug therapy with catheter ablation using the SmartTOUCH catheter (Biosense Webster Inc.) as treatment for patients with ventricular tachycardia and coronary artery disease

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.
Cronin EM, Bogun FM, Maury P, Peichl P, et al · · 2019 · cited 286× · PMID 31075787 · DOI 10.1093/europace/euz132
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.
Cronin EM, Bogun FM, Maury P, Peichl P, et al · · 2020 · cited 232× · PMID 31085023 · DOI 10.1016/j.hrthm.2019.03.002
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.
Cronin EM, Bogun FM, Maury P, Peichl P, et al · · 2019 · cited 32× · PMID 31293696 · DOI 10.1002/joa3.12185
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.
Cronin EM, Bogun FM, Maury P, Peichl P, et al · · 2020 · cited 24× · PMID 31984466 · DOI 10.1007/s10840-019-00663-3

Verify or expand the search:

Other trials of Catheter Ablation

Trials testing the same drug.

NCT07403760 — Wellbeing and Survival Improvement With Event Reduction by Ablation for Atrial Fibrillation in the Very Elderly · NA · recruiting
NCT07017855 — Stereotactic Radiosurgery as Second-line Therapy for Ventricular Tachycardia · NA · not yet recruiting
NCT06747091 — ARIADNE Clinical Trial · NA · recruiting
NCT07096219 — Catheter Ablation for Functional Mitral Regurgitation in Persistent Atrial Fibrillation: Development and Validation of a · enrolling by invitation
NCT06505798 — Cryoballoon/Radiofrequency/Pulsed Field Ablation of Atrial Fibrillation Versus Medical Treatment for Heart · NA · recruiting

Other recruiting trials for Ventricular Tachycardia

Currently open trials in the same condition.

NCT07201506 — Real-Time Intracardiac Echocardiography for Ventricular Arrhythmia Ablation · NA · recruiting
NCT06360939 — Radiotherapy vs Catheter Ablation for Ventricular Tachycardia in Structural Heart Disease · NA · recruiting
NCT07116525 — A Study Assessing Arrhythmia Mapping With a Multi-Electrode Mapping Catheter · NA · recruiting
NCT06891456 — Pulsed Field Ablation for Post-Infarction Ventricular Tachycardia · NA · recruiting
NCT06592001 — Assessment of a Chronically Implanted Parasternally Delivered EV-ICD Lead (ASCEND EV) Study · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01798277 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Newmarket Electrophysiology Research Group Inc
Last refreshed: 26 January 2015

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01798277.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing